España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BridgeBio Pharma
BBIO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$26.49
0.28
1.07%
At close: -
$26.49
0.00050
0.00%
After Hours: Dec 20, 4:01 PM EDT
Get Report
Comment
BridgeBio Pharma (BBIO) Forecast
News
Earnings
BridgeBio Pharma (BBIO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BridgeBio Pharma (NASDAQ:BBIO) Stock
BridgeBio Pharma Stock (NASDAQ: BBIO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 16, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Friday, December 13, 2024
Bridgebio Pharma Says Committee For Medicinal...
Benzinga Newsdesk
Tuesday, December 03, 2024
Unnatural Products Announces BridgeBio Exerci...
Benzinga Newsdesk
Monday, November 25, 2024
Scotiabank Maintains Sector Outperform on Bri...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Gold Down Over 3%; Rigetti Computing Shares Spike Higher
Avi Kapoor
Crude Oil Down 3%; Chicago Fed National Activity Index Falls In October
Avi Kapoor
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Avi Kapoor
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Vandana Singh
B of A Securities Maintains Buy on BridgeBio ...
Benzinga Newsdesk
BridgeBio Pharma shares are trading higher af...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on BridgeBi...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:05:00 ...
Benzinga Newsdesk
Reported Friday, BridgeBio's Attruby Earns FD...
Benzinga Newsdesk
Friday, November 22, 2024
Trading Halt: Halted at 4:08:53 p.m. ET - Tra...
Benzinga Newsdesk
Tuesday, November 19, 2024
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
Vandana Singh
Monday, November 18, 2024
BridgeBio Pharma Says The Continued Curve Sep...
Benzinga Newsdesk
BridgeBio Pharma Presented Initial Outcomes F...
Benzinga Newsdesk
BridgeBio's Achondroplasia Treatment Shows 18...
Benzinga Newsdesk
Friday, November 15, 2024
Scotiabank Maintains Sector Outperform on Bri...
Benzinga Newsdesk
Tuesday, November 12, 2024
BridgeBio Pharma shares are trading lower aft...
Benzinga Newsdesk
BridgeBio Pharma Q3 2024 GAAP EPS $(0.86) Bea...
Benzinga Newsdesk
Friday, October 25, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Thursday, October 24, 2024
BridgeBio Presents Positive Preliminary Data ...
Benzinga Newsdesk
Wednesday, October 16, 2024
BridgeBio Pharma shares are trading higher af...
Benzinga Newsdesk
Scotiabank Initiates Coverage On BridgeBio Ph...
Benzinga Newsdesk
Thursday, October 03, 2024
Oppenheimer Initiates Coverage On BridgeBio P...
Benzinga Newsdesk
BridgeBio Pharma Announced That Outcomes Data...
Benzinga Newsdesk
Wednesday, October 02, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Monday, September 30, 2024
BridgeBio Pharma's Lead Candidate Cuts Mortality, Related Hospitalizations In Patients With Certain Type Of Heart Disease
Vandana Singh
BridgeBio Pharma Has Completed Enrollment Of ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Reported Earlier, BridgeBio's Acoramidis Show...
Benzinga Newsdesk
Tuesday, September 24, 2024
Check Out What Whales Are Doing With BBIO
Benzinga Insights
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
BridgeBio Pharma Says FDA Has Granted Breakth...
Benzinga Newsdesk
Monday, September 16, 2024
Cantor Fitzgerald Reiterates Overweight on Br...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Wednesday, September 11, 2024
BridgeBio Pharma Seeks Partner To Develop Gene Therapy For Inherited Condition
Vandana Singh
B of A Securities Maintains Buy on BridgeBio ...
Benzinga Newsdesk
Tuesday, September 10, 2024
BridgeBio To No Longer Be Pursuing Developmen...
Benzinga Newsdesk
BridgeBio Reports Results From Phase 1/2 Tria...
Benzinga Newsdesk
BridgeBio Says FDA Granted Regenerative Medic...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Br...
Benzinga Newsdesk
Wednesday, September 04, 2024
Piper Sandler Initiates Coverage On BridgeBio...
Benzinga Newsdesk
Tuesday, September 03, 2024
Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on BridgeB...
Benzinga Newsdesk
Friday, August 30, 2024
Why Is BridgeBio Pharma Stock Trading Higher On Friday?
Vandana Singh
BridgeBio Shares Data On Serum TTR Increase W...
Benzinga Newsdesk
Marvell Technology Posts Upbeat Sales, Joins MongoDB, Intel, MINISO Group And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch